Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Generic Pharmaceutical dealmaking

2.1. Introduction
2.2. Generic Pharmaceutical partnering over the years
2.3. Most active Generic Pharmaceutical dealmakers
2.4. Generic Pharmaceutical partnering by deal type
2.5. Generic Pharmaceutical partnering by therapy area
2.6. Generic Pharmaceutical partnering by technology type
2.7. Deal terms for Generic Pharmaceutical partnering
2.7.1 Generic Pharmaceutical partnering headline values
2.7.2 Generic Pharmaceutical deal upfront payments
2.7.3 Generic Pharmaceutical deal milestone payments
2.7.4 Generic Pharmaceutical royalty rates

Chapter 3 – Leading Generic Pharmaceutical deals

3.1. Introduction
3.2. Top Generic Pharmaceutical deals by value

Chapter 4 – Most active Generic Pharmaceutical dealmakers

4.1. Introduction
4.2. Most active Generic Pharmaceutical dealmakers
4.3. Most active Generic Pharmaceutical partnering company profiles

Chapter 5 – Generic Pharmaceutical contracts dealmaking directory

5.1. Introduction
5.2. Generic Pharmaceutical contracts dealmaking directory

Chapter 6 – Generic Pharmaceutical dealmaking by technology type

Chapter 7 – Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 – Generic Pharmaceutical deals by company A-Z
Appendix 2 – Generic Pharmaceutical deals by stage of development
Appendix 3 – Generic Pharmaceutical deals by deal type
Appendix 4 – Generic Pharmaceutical deals by therapy area
Appendix 5 – Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Generic Pharmaceutical partnering since 2010
Figure 2: Active Generic Pharmaceutical dealmaking activity– 2010 to 2020
Figure 3: Generic Pharmaceutical partnering by deal type since 2010
Figure 4: Generic Pharmaceutical partnering by disease type since 2010
Figure 5: Generic Pharmaceutical partnering by technology type since 2010
Figure 6: Generic Pharmaceutical deals with a headline value
Figure 7: Generic Pharmaceutical deals with an upfront value
Figure 8: Generic Pharmaceutical deals with a milestone value
Figure 9: Generic Pharmaceutical deals with a royalty rate value
Figure 10: Top Generic Pharmaceutical deals by value since 2010
Figure 11: Most active Generic Pharmaceutical dealmakers 2010 to 2020